Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosecurity

    Leidos Awarded Plum Island Contract by DHS

    By Global Biodefense StaffJune 2, 2014
    Share
    Facebook LinkedIn Reddit Email

    The U.S. Department of Homeland Security (DHS) has awarded a prime contract to Leidos (formerly known as SAIC) to support and supplement the Science and Technology (S&T) Agricultural Scientific Program at the Plum Island Animal Disease Center (PIADC).

    The contract has a one-year base period of performance, four one-year options and a total contract value of approximately $12 million if all options are exercised. Work will be performed in Orient Point, N.Y.

    PIADC is the only laboratory in the nation that can work on high-consequence foreign animal diseases. The laboratory helps protect U.S. livestock from the accidental or intentional introduction of foreign animal diseases. Based on the breadth of this mission, the DHS S&T Agricultural Defense Scientific Program at the PIADC is critical to the development of Foreign Animal Disease countermeasures that can be deployed in the event of an outbreak, including vaccines, diagnostic technology and biotherapeutics.

    Under the contract, Leidos will support and supplement the DHS S&T Agricultural Defense Scientific Program at PIADC with planning, program management support and oversight for the development of vaccines, diagnostics and other countermeasures to mitigate the impact of Foreign Animal Diseases.

    “We are pleased to continue our support to the DHS S&T Directorate to protect U.S. livestock from foreign animal diseases that can seriously threaten our livestock industries, economy, and way of life,” said President of Leidos Health, Steve Comber.

    Agro-Defense Animal Models Biosafety Consequence Management
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleCholera Vaccine Highly Effective During Outbreak in Guinea
    Next Article New Coronavirus Inhibitor Exhibits Potent Antiviral Activity

    Related Stories

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    Bird Flu Undergoing Changes That Could Increase Risk of Widespread Human Transmission

    September 14, 2023

    NIAID Study Shows Low-Dose Marburg Vaccine Effective in Macaques

    August 25, 2023

    Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus

    August 24, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy